Bicara Therapeutics Inc. (BCAX)

NGM – Real Time Price. Currency in USD

24.64

+0.88 (3.70%)

Market open: Aug 12, 2026, 2:49 PM EDT

23.77

+0.01 (0.04%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

12.08.2026

Bicara Therapeutics Analysts Raise Their Forecasts After Q2 Results

Bicara Therapeutics Inc (NASDAQ:BCAX) reported a narrower-than-expected loss for the second quarter on Tuesday.

11.08.2026

Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript

11.08.2026

Bicara Therapeutics Q2 Earnings Call Highlights

Bicara Therapeutics NASDAQ: BCAX used its second-quarter 2026 earnings call to outline leadership changes, progress in its pivotal head and neck cancer program and plans to expand development of ficerafusp alfa, or FICERA, while reaffirming its cash runway into the first half of 2029.

04.08.2026

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that it will report second quarter 2026 financial results and business updates before the market opens on Tuesday, August 11, 2026. Bicara will host a conference call to discuss the financial results and business updates at 8:30 a.m. ET the same day. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and a unique PIN that will allow them to access the call. To access the live webcast, please visit the “Events & Presentations” section within the Investors page on the Bicara website. A replay of the webcast will be available for 30 days following the event.

Videos

No Data

There is no data to display

Bicara Therapeutics Inc. (BCAX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Analysts Raise Their Forecasts After Q2 Results

Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript

Bicara Therapeutics Q2 Earnings Call Highlights

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET

Videos

No Data

Bicara Therapeutics Analysts Raise Their Forecasts After Q2 Results

Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript

Bicara Therapeutics Q2 Earnings Call Highlights

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET

Videos

No Data

Search stocks

Bicara Therapeutics Inc. (BCAX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Analysts Raise Their Forecasts After Q2 Results

Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript

Bicara Therapeutics Q2 Earnings Call Highlights

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET

Videos

No Data

Bicara Therapeutics Analysts Raise Their Forecasts After Q2 Results

Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript

Bicara Therapeutics Q2 Earnings Call Highlights

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET

Videos

No Data